News
In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like Ozempic, Eli Lilly has said., Health, Times Now ...
Lupin launches Glucagon for Injection USP in emergency kit, bioequivalent to Eli Lilly's product, with $122M annual sales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback